Precigen (PGEN) EBITDA Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Precigen (PGEN) EBITDA Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 375,193.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 375,193.00 |
| Mar 31, 2026 | 165,923.00 |
| Dec 31, 2025 | 192,169.00 |
| Sep 30, 2025 | 105,101.00 |
| Jun 30, 2025 | 477,475.00 |
| Mar 31, 2025 | 60,701.00 |
| Dec 31, 2024 | 39,067.00 |
| Sep 30, 2024 | -71,279.00 |
| Jun 30, 2024 | -729,025.00 |
| Mar 31, 2024 | -102,362.00 |
| Dec 31, 2023 | -155,061.00 |
| Sep 30, 2023 | -147,274.00 |
| Jun 30, 2023 | -36,522.00 |
| Mar 31, 2023 | -86,656.00 |
| Dec 31, 2022 | -64,266.00 |
| Sep 30, 2022 | 60,043.00 |
| Jun 30, 2022 | -14,284.00 |
| Mar 31, 2022 | -32,967.00 |
| Dec 31, 2021 | -40,882.00 |
| Sep 30, 2021 | -55,772.00 |